Stay updated with breaking news from James Hao. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Late-breaking phase 3 data for KONFIDENT trial on Sunday, February 25, 2024 – ...
– Late-breaking phase 3 data for KONFIDENT trial on Sunday, February 25, 2024 –CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--$KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule pro...
Students selected for the Undergraduate Summer Training in Cardiovascular Research program receive a stipend and are paired with a faculty mentor and work full-time in their laboratories.